Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the…
BALTIMORE, April 27, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the…